MDMA therapy for veterans with PTSD and alcohol use
Part of Mental health clinical trials.
This study tests whether MDMA-assisted therapy can help veterans who have both PTSD and alcohol use disorder. If you have tried a standard therapy before and want to reduce or stop drinking, this treatment may offer a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a veteran enrolled in VA care.
- You have tried at least one standard therapy for PTSD and/or alcohol use.
- You have had PTSD symptoms for at least 6 months and still have moderate to severe symptoms.
- You have had alcohol use disorder in the past 3 months and want to cut back or quit.
- You can safely stop drinking for 48 hours without needing medical detox.
- You are not pregnant, can swallow pills, and have a support person to stay with you after sessions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether MDMA, given in a controlled clinical setting, can reduce symptoms of PTSD and alcohol use disorder in veterans. It also combines the medication with structured therapy sessions to help you manage symptoms without relying on alcohol or other substances.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
This study tests whether MDMA (the active ingredient in Ecstasy) given in therapy sessions can help Israeli special forces veterans with PTSD and moral injury. Participants will receive MDMA alongside talk therapy to see if it reduces symptoms.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.